Researchers discover how a neurotoxin commonly used for cosmetic procedures can travel into the CNS.
A new study reports Botox treatments temporarily block proprioceptive feedback, essentially making it difficult for others to read emotion from facial expressions.
Researchers pinpoint a method to neutralize the Botox toxin.
Researchers report botox may spread from the injection site to produce symptoms consistent with botulism, including muscle weakness and breathing problems.
A new method of growing neural networks from stem cells is capable of detecting the activity of Clostridium botulinum neurotoxins and could help to minimize animal research.
A new study backs up previous research regarding the effectiveness of ketamine in treating depression. Additionally, researchers identified antidepressant effects in Botox, Diclofenac and Minocycline, drugs commonly used for other purposes.
Researchers have identified a new active botulinum neurotoxin. The discovery could lead to the development of new protein therapeutics.
According to researchers, Botulinum toxin, or Botox, injections can help to reduce the frequency of chronic migraines. Compared to those treated with a placebo, migraine suffers experienced 1.6 fewer attacks per month following Botox injections.
Many people who suffer migraines are often diagnosed with other conditions. For those with a clinical diagnosis, many are unaware of treatment options available for pain and to slow the frequency of attacks.
Botox injections appear to improve symptoms of depression, regardless of the injection site, a new study reports. Researchers found depression was reported 40 - 88% less often in patients treated with Botox.
Genetically engineering botulinum toxin could help advance new treatments for everything from neurodegenerative disorders to cytokine storms.
Dopamine neurons largely rely on their own discharge to determine release rates of the hormone, researchers report.
